Product Code: ETC100303 | Publication Date: Jul 2023 | Updated Date: Feb 2025 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
The India human insulin market is expected to grow at a CAGR of 12.5 % during on account of increasing prevalence of diabetes, rising awareness about the disease and availability of cost-effective insulin products in the country.
The primary drivers for the growth of Indiahuman insulin market are increasing prevalence of diabetes, rising awareness about the disease among people, growing demand for innovative drug delivery systems such as pen injectors and pumps, and government initiatives such as National Diabetes Control Program (NDCP). In addition, factors such as increasing urbanization, changing dietary habits amongst population and lack physical activities have contributed to an increase in diabetic cases over time which has further propelled market growth. Moreover, technological advancements in biologics production processes followed by introduction/launch low-cost generic versions have made it affordable to wider sections of consumers. These factors are likely to propel growth during forecast period.
The major challenge limiting sales include poor reimbursement policies in India coupled with limited affordability due to high costs associated with these drugs and lack access across rural areas where majority population resides thus hampering sales opportunities for players operating in this space. Also presence regulatory barriers restricts entry new competitors hence leading o higher price points that tends discourage end user from buying these expensive drugs. Furthermore , failure or inadequate trial results may lead significant losses investments along delays commercialization process which another factor restraining industry expansion
Major companies operating within India human insulin market include Novo Nordisk A/s., Eli Lilly And Company Biocon Ltd., Sanofi S A., Wockhardt Limited , Merck & Co Inc.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Human Insulin Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Human Insulin Market Revenues & Volume, 2021 & 2031F |
3.3 India Human Insulin Market - Industry Life Cycle |
3.4 India Human Insulin Market - Porter's Five Forces |
3.5 India Human Insulin Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 India Human Insulin Market Revenues & Volume Share, By Diabetes Type, 2021 & 2031F |
3.7 India Human Insulin Market Revenues & Volume Share, By Delivery Devices, 2021 & 2031F |
3.8 India Human Insulin Market Revenues & Volume Share, By End-users, 2021 & 2031F |
4 India Human Insulin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 India Human Insulin Market Trends |
6 India Human Insulin Market, By Types |
6.1 India Human Insulin Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 India Human Insulin Market Revenues & Volume, By Type, 2018 - 2031F |
6.1.3 India Human Insulin Market Revenues & Volume, By Analogue Insulin, 2018 - 2031F |
6.1.4 India Human Insulin Market Revenues & Volume, By Traditional Human Insulin, 2018 - 2031F |
6.2 India Human Insulin Market, By Diabetes Type |
6.2.1 Overview and Analysis |
6.2.2 India Human Insulin Market Revenues & Volume, By Type 1 Diabetes, 2018 - 2031F |
6.2.3 India Human Insulin Market Revenues & Volume, By Type 2 Diabetes, 2018 - 2031F |
6.2.4 India Human Insulin Market Revenues & Volume, By Gestational Diabetes, 2018 - 2031F |
6.2.5 India Human Insulin Market Revenues & Volume, By Prediabetes, 2018 - 2031F |
6.3 India Human Insulin Market, By Delivery Devices |
6.3.1 Overview and Analysis |
6.3.2 India Human Insulin Market Revenues & Volume, By Syringes, 2018 - 2031F |
6.3.3 India Human Insulin Market Revenues & Volume, By Pens, 2018 - 2031F |
6.3.4 India Human Insulin Market Revenues & Volume, By Pumps, 2018 - 2031F |
6.3.5 India Human Insulin Market Revenues & Volume, By Others, 2018 - 2031F |
6.4 India Human Insulin Market, By End-users |
6.4.1 Overview and Analysis |
6.4.2 India Human Insulin Market Revenues & Volume, By Home Healthcare, 2018 - 2031F |
6.4.3 India Human Insulin Market Revenues & Volume, By Hospitals, 2018 - 2031F |
6.4.4 India Human Insulin Market Revenues & Volume, By Over The Counter (OTC), 2018 - 2031F |
6.4.5 India Human Insulin Market Revenues & Volume, By Clinics, 2018 - 2031F |
6.4.6 India Human Insulin Market Revenues & Volume, By Others, 2018 - 2031F |
7 India Human Insulin Market Import-Export Trade Statistics |
7.1 India Human Insulin Market Export to Major Countries |
7.2 India Human Insulin Market Imports from Major Countries |
8 India Human Insulin Market Key Performance Indicators |
9 India Human Insulin Market - Opportunity Assessment |
9.1 India Human Insulin Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 India Human Insulin Market Opportunity Assessment, By Diabetes Type, 2021 & 2031F |
9.3 India Human Insulin Market Opportunity Assessment, By Delivery Devices, 2021 & 2031F |
9.4 India Human Insulin Market Opportunity Assessment, By End-users, 2021 & 2031F |
10 India Human Insulin Market - Competitive Landscape |
10.1 India Human Insulin Market Revenue Share, By Companies, 2024 |
10.2 India Human Insulin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |